Видео ютуба по тегу Medicines: Astx727

10-day ASTX727 (decitabine/cedazuridine) with venetoclax in the treatment of R/R AML
10-day ASTX727 (decitabine/cedazuridine) with venetoclax in the treatment of R/R AML
The efficacy of low-dose ASTX727 in low-risk MDS
The efficacy of low-dose ASTX727 in low-risk MDS
ASTX727 plus venetoclax: Phase I study of total oral therapy for high-risk MDS/CMML
ASTX727 plus venetoclax: Phase I study of total oral therapy for high-risk MDS/CMML
Oral combination of ASTX727 (decitabine/cedazuridine) plus Ven for older/unfit patients with AML
Oral combination of ASTX727 (decitabine/cedazuridine) plus Ven for older/unfit patients with AML
Updates from a study evaluating ASTX727 + venetoclax for patients with AML
Updates from a study evaluating ASTX727 + venetoclax for patients with AML
Safety and efficacy of ASTX727 in patients with CMML from Phase II and Phase III ASCERTAIN studies
Safety and efficacy of ASTX727 in patients with CMML from Phase II and Phase III ASCERTAIN studies
ASTX727 + a molecularly-targeted agent as personalized maintenance therapy in patients with AML
ASTX727 + a molecularly-targeted agent as personalized maintenance therapy in patients with AML
Promising results in MDS for ASTX727, an oral decitabine and cytidine deaminase inhibitor agent
Promising results in MDS for ASTX727, an oral decitabine and cytidine deaminase inhibitor agent
NIBIT-ML1: ipilimumab and nivolumab with ASTX727 in PD-1 resistant melanoma
NIBIT-ML1: ipilimumab and nivolumab with ASTX727 in PD-1 resistant melanoma
Updates on a phase 2 confirmation study of oral ASTX727 in patients with MDS
Updates on a phase 2 confirmation study of oral ASTX727 in patients with MDS
Phase II trial in progress: ASTX727 ± venetoclax in newly diagnosed MDS/MPN
Phase II trial in progress: ASTX727 ± venetoclax in newly diagnosed MDS/MPN
Emerging treatment strategies for CMML
Emerging treatment strategies for CMML
2024.05 Ep 5: The GIGO Principle: Inappropriate CAP Diagnosis Results in Unnecessary Antibiotic E...
2024.05 Ep 5: The GIGO Principle: Inappropriate CAP Diagnosis Results in Unnecessary Antibiotic E...
Medications Used In Arthritis - Dr. Murphy
Medications Used In Arthritis - Dr. Murphy
Treatment with decitabine resulted in a similar survival and fewer adverse events compared with ...
Treatment with decitabine resulted in a similar survival and fewer adverse events compared with ...
Webinar Series - Medications
Webinar Series - Medications
MDS Management: ASCERTAIN Equivalence Study
MDS Management: ASCERTAIN Equivalence Study
How to come off useless medicines safely: TOP TIPS from a consultant geriatrician
How to come off useless medicines safely: TOP TIPS from a consultant geriatrician